Physician profile
Eric S Franklin
NPI 1235265646
$6,054.37
in general payments reported to CMS, 2019-2025
30 companies · $2,043 in 2025
The $2,043 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $148 · 2023: $1,132 · 2024: $2,731 · 2025: $2,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,256 · Travel and Lodging: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,256.09 |
| Travel and Lodging | $649.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,070.21 | 2022-2025 | Watchman Flx, Watchman, Enroute Transcarotid Stent |
| Alnylam Pharmaceuticals INC. | $558.60 | 2023-2025 | Amvuttra, Onpattro |
| E.R. Squibb & Sons, L.L.C. | $377.95 | 2023-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $337.41 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $331.48 | 2023-2025 | Andexxa, Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $326.46 | 2023-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $319.58 | 2023-2025 | Lifevest |
| Novo Nordisk INC | $310.01 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $215.71 | 2023-2025 | Repatha, Repatha |
| Philips North America LLC | $184.65 | 2023-2025 | (Am5) Lead Management, (Ck4) Mcot, Mcot |
| Edwards Lifesciences Corporation | $160.01 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $127.81 | 2022-2023 | Xarelto |
| Abbott Laboratories | $127.45 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Lexicon Pharmaceuticals, INC. | $109.12 | 2023-2024 | Inpefa |
| Daiichi Sankyo INC. | $107.47 | 2024-2025 | Injectafer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $77.02 | 2025 | |
| Pfizer INC. | $48.37 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.71 | 2023 | Jardiance |
| Chiesi USA, INC. | $29.63 | 2023-2024 | Kengreal, Cleviprex |
| Cvrx, INC. | $23.00 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $21.45 | 2024 | Evkeeza |
| Baxter Healthcare | $20.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Silk Road Medical, INC. | $18.74 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Abiomed | $18.10 | 2025 | |
| Scpharmaceuticals INC. | $17.45 | 2024 | |
| Altathera Pharmaceuticals LLC | $16.48 | 2023 | Sotalol Hydrochloride |
| Lilly USA, LLC | $15.99 | 2025 | Zepbound |
| Angiodynamics, INC. | $15.75 | 2025 | Alphavac |
| Kiniksa Pharmaceuticals International, Plc | $14.45 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $13.25 | 2024 | Zio Monitor, Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.